Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trial.

Nolan T, Bhusal C, Beran J, Bloch M, Cetin BS, Dinleyici EC, Dražan D, Kokko S, Koski S, Laajalahti O, Langley JM, Rämet M, Richmond PC, Silas P, Tapiero B, Tiong F, Tipton M, Ukkonen B, Ulukol B, Lattanzi M, Trapani M, Willemsen A, Toneatto D, QUINTET study group

Open source

DOI: 10.1016/s1473-3099(24)00667-4
Published: 2025 May
Container: The Lancet. Infectious diseases
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1473-3099-24-00667-4,
  title = {Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trial.},
  author = {Nolan T and Bhusal C and Beran J and Bloch M and Cetin BS and Dinleyici EC and Dražan D and Kokko S and Koski S and Laajalahti O and Langley JM and Rämet M and Richmond PC and Silas P and Tapiero B and Tiong F and Tipton M and Ukkonen B and Ulukol B and Lattanzi M and Trapani M and Willemsen A and Toneatto D and QUINTET study group},
  year = {2025},
  journal = {The Lancet. Infectious diseases},
  doi = {10.1016/s1473-3099(24)00667-4},
  url = {https://doi.org/10.1016/s1473-3099(24)00667-4}
}

RIS

TY  - JOUR
TI  - Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trial.
AU  - Nolan T
AU  - Bhusal C
AU  - Beran J
AU  - Bloch M
AU  - Cetin BS
AU  - Dinleyici EC
AU  - Dražan D
AU  - Kokko S
AU  - Koski S
AU  - Laajalahti O
AU  - Langley JM
AU  - Rämet M
AU  - Richmond PC
AU  - Silas P
AU  - Tapiero B
AU  - Tiong F
AU  - Tipton M
AU  - Ukkonen B
AU  - Ulukol B
AU  - Lattanzi M
AU  - Trapani M
AU  - Willemsen A
AU  - Toneatto D
AU  - QUINTET study group
PY  - 2025
JO  - The Lancet. Infectious diseases
DO  - 10.1016/s1473-3099(24)00667-4
UR  - https://doi.org/10.1016/s1473-3099(24)00667-4
ER  -

APA

T, N., C, B., J, B., M, B., BS, C., EC, D., D, D., S, K., S, K., O, L., JM, L., M, R., PC, R., P, S., B, T., F, T., M, T., B, U., B, U., M, L., M, T., A, W., D, T., & group, Q. S. (2025). Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trial.. The Lancet. Infectious diseases. https://doi.org/10.1016/s1473-3099(24)00667-4

Source records

pubmed · retrieved 2026-09-26T01:29:49.863Z